Central GABA receptor agonists: comparison of muscimol and baclofen.
D000613:Aminobutyrates / Q000494:pharmacology* / Q000502:physiology*; D000818:Animals; D000927:Anticonvulsants; D001418:Baclofen / Q000494:pharmacology*; D002531:Cerebellum / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D003975:Diazepam / Q000494:pharmacology; D006246:Harmaline / Q000494:pharmacology; D007538:Isoniazid / Q000037:antagonists & inhibitors; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009129:Muscle Tonus / Q000187:drug effects; D009183:Mycotoxins / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology*; D010634:Phenobarbital / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D013331:Strychnine / Q000037:antagonists & inhibitors; D013373:Substance P / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D000613:Aminobutyrates; D000927:Anticonvulsants; D009183:Mycotoxins; D010080:Oxazoles; D000644:Quaternary Ammonium Compounds; D011955:Receptors, Drug; D013373:Substance P; D005680:gamma-Aminobutyric Acid; D006246:Harmaline; D006152:Cyclic GMP; D001418:Baclofen; D013331:Strychnine; D003975:Diazepam; D007538:Isoniazid; D010634:Phenobarbital